milrinone has been researched along with Brain Vascular Disorders in 3 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Thunderclap headache is the most common clinical manifestation; however, other symptoms can result from complications of the disease, such as stroke, brain edema, and seizures." | 5.62 | Reversible Cerebral Vasoconstriction Syndrome in a Background of Eclampsia Responding to Milrinone Infusion. ( Aldandan, HW; Alrayes, MM; Alshagawi, ZA; Alzahrani, SK; Hadhiah, KM, 2021) |
| "Thunderclap headache is the most common clinical manifestation; however, other symptoms can result from complications of the disease, such as stroke, brain edema, and seizures." | 1.62 | Reversible Cerebral Vasoconstriction Syndrome in a Background of Eclampsia Responding to Milrinone Infusion. ( Aldandan, HW; Alrayes, MM; Alshagawi, ZA; Alzahrani, SK; Hadhiah, KM, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hadhiah, KM | 1 |
| Alshagawi, ZA | 1 |
| Alzahrani, SK | 1 |
| Alrayes, MM | 1 |
| Aldandan, HW | 1 |
| Khandelwal, A | 1 |
| Kumar, N | 1 |
| Hawkes, MA | 1 |
| Hlavnicka, AA | 1 |
| Wainsztein, NA | 1 |
3 other studies available for milrinone and Brain Vascular Disorders
| Article | Year |
|---|---|
Reversible Cerebral Vasoconstriction Syndrome in a Background of Eclampsia Responding to Milrinone Infusion.
Topics: Adult; Cerebrovascular Disorders; Eclampsia; Female; Headache Disorders, Primary; Humans; Milrinone; | 2021 |
Reply to "Reversible Cerebral Vasoconstriction Syndrome Responsive to Intravenous Milrinone".
Topics: Administration, Intravenous; Cerebrovascular Disorders; Humans; Milrinone; Vasoconstriction; Vasospa | 2020 |
Reply to "Reversible Cerebral Vasoconstriction Syndrome Responsive to Intravenous Milrinone".
Topics: Administration, Intravenous; Cerebrovascular Disorders; Humans; Milrinone; Vasoconstriction; Vasospa | 2020 |